BABA
Alibaba Group Holding Limited
BABA's fundamentals are weak: its operating margin fell 10 points to 4.2% and free cash flow turned negative, though revenue grew 4.3%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
REBN
Reborn Coffee, Inc.
There isn't enough reported data to score REBN yet.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
REBN Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
REBN's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | โ |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.
REBN PE Valuation
REBN has no meaningful PE right now: it lost money over the past year.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for BABA, with profitability improving. However, they disagree widely on these estimates.
REBN Forward outlook
There aren't enough analyst estimates for REBN to show an outlook.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA has the edge over REBN on earnings quality, reporting a profit while its opponent remains loss making.
REBN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.65 | +$1.55 |
| Q1 2026 | -$1.48 | +$0.05 |
| Q4 2025 | -$1.73 | -$0.07 |
| Q3 2025 | -$2.58 | -$0.23 |
| Q2 2025 | -$2.20 | +$0.33 |
| Q1 2025 | -$1.53 | +$1.32 |
| Q4 2024 | -$1.66 | +$1.23 |
| Q3 2024 | -$2.35 | +$0.35 |
REBN is still losing money, but far less than before: $0.65 per share over the past year, against $2.89 at its worst in late 2023.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA's revenue has grown year over year for 16 quarters in a row: $40.2B last quarter, up 8.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA has the edge over REBN on profitability, with a higher operating margin.
REBN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $6.3M | +245% |
| Q1 2026 | $5.2M | +208% |
| Q4 2025 | $3.2M | +80% |
| Q3 2025 | $1.4M | +7.8% |
| Q2 2025 | $1.8M | +34% |
| Q1 2025 | $1.7M | +12% |
| Q4 2024 | $1.8M | +31% |
| Q3 2024 | $1.3M | -17% |
REBN's revenue has grown year over year for seven quarters in a row: $6M last quarter, up 245% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -25% | +215 points |
| Q1 2026 | -17% | +84 points |
| Q4 2025 | 105% | +200 points |
| Q3 2025 | -225% | -167 points |
| Q2 2025 | -240% | -143 points |
| Q1 2025 | -100% | -43 points |
| Q4 2024 | -95% | +27 points |
| Q3 2024 | -58% | -9.2 points |
REBN's operating margin was โ25% last quarter, up 215 points from the same quarter a year ago.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
REBN has the stronger cash trend. Its trailing FCF is down 42% versus its history, compared with BABA at down 158%.
REBN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$1.7M | -$1.1M |
| Q3 2025 | -$1.6M | -$1.2M |
| Q4 2024 | -$600.9K | +$1.3M |
| Q3 2024 | -$424K | -114% |
| Q2 2024 | -$615.9K | +$4M |
| Q1 2024 | -$2.9M | -$786.7K |
| Q4 2023 | -$1.9M | -$206.3K |
| Q3 2023 | $3M | +$3.9M |
REBN has burned cash in almost every quarter: โ$5M over the past year, against โ$5M the year before.
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA's net debt is less than a year of its operating earnings (EBITDA).
REBN Net Leverage
REBN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
REBN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.7 | Neutral |
| Stochastic | 38.7 | Neutral |
REBN's weekly RSI is 43 (neutral) and its Stochastic is 39 (neutral).
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA is trading at 21x earnings, a 19% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
REBN PE vs Consumer Cyclical Sector
REBN has no meaningful PE right now: it lost money over the past year.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
REBN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.54 | 32% below |
| 20 week MA | $1.37 | 23% below |
| 50 week MA | $1.69 | 38% below |
| 100 week MA | $2.21 | 52% below |
| 200 week MA | $3.34 | 69% below |
REBN is in a downtrend: it's below all five of its weekly moving averages, and 69% below its 200-week average.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has finished lower in three of the last six years. It's down 38% so far in 2026.
REBN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $38.4 | $6.24 | -84% |
| 2023 | $6.24 | $4.56 | -27% |
| 2024 | $4.56 | $1.80 | -61% |
| 2025 | $1.80 | $1.47 | -18% |
| 2026 YTD | $1.47 | $1.05 | -29% |
REBN has the edge over BABA on returns for 2026, with the stronger performance.